Form D · Other Technology

Sequelae, Inc.

Minneapolis, MN · CIK 0002019160

Offering snapshot reported Nov 18, 2025 · SEC filing

Reported sold
$223K
Offering amount: $1.49M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 7, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 18, 2025Initial$222,750No comparison2SEC filing
May 8, 2024Initial$20,000,000No comparison2SEC filing
Apr 12, 2024Initial$60,000,000No comparison7SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-564316

Source: Form D, filed Nov 18, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mark Briesacher Executive
Mike Christy Executive
Ken Ehlert Director, Executive
Shiraz Fagan Executive
Rushika Fernandopulle Director
Gregory Johnson Executive
Mark Pollman Executive
Mark Pollmann Executive
Amy Schulman Director
Sara Taylor Executive
David Wichman Director
David Wichmann Director
Albert Zimmerli Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
80 S 8 Th St #3100
Minneapolis, MN, 55402